All In Biotech

Drug Trial Radar · NCT06454357

A Clinical Study of B007 in the Treatment of Pemphigus.

A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of B007 in Subjects With Pemphigus.

Last checked: Nov 19, 2026Latest source record: May 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

132

Planned (sponsor's estimate)

Start

Jul 12, 2024

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Sponsor type
Industry
Collaborators
Shanghai Pharmaceuticals Holding Co., Ltd
First posted
Jun 12, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of B007 in subjects with pemphigus.

Conditions

  • Pemphigus

Interventions

  • B007Drug

    B007:high dose/low dose: Subcutaneous injection was administered on days 1 and 15

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of subjects:Complete remission with minimal treatmentTime frame: Approximately36 weeks

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Peking University First Hospital

    Beijing, China · Recruiting

  • The Second Xiangya Hospital of Central South University

    Changsha, China · Recruiting

  • Chengdu Second People's Hospital

    Chengdu, China · Recruiting

  • West China Hospital, Sichuan University

    Chengdu, China · Recruiting

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, China · Recruiting

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, China · Recruiting

  • Dermatology Hospital of Southern Medical University

    Guangzhou, China · Recruiting

  • Guangdong Provincial People's Hospital

    Guangzhou, China · Recruiting

  • Shandong First Medical University-Affiliated Skin Hospital

    Jinan, China · Recruiting

  • Ruijin Hospital, Shanghai Jiaotong University School of Medicine

    Shanghai, China · Recruiting

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, China · Recruiting

  • Henan Provincial People's Hospital

    Zhengzhou, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.